Read more
This book explores the role of the gut microbiome in cancer initiation, progression, and treatment response to present gut microbiome biomarkers for cancer diagnosis and strategies for modulating microbiome for personalized cancer therapies. The work is intended for cancer researchers, medical oncologists, clinicians, and pharmacologists.
List of contents
Chapter 1. Introduction to the Gut Microbiome and Cancer. Chapter 2. Gut Microbiome Dysbiosis and Cancer Risk. Chapter 3. Gut Microbiome and Cancer Treatment Response. Chapter 4. Gut Microbiome Modulation for Personalized Cancer Therapies. Chapter 5. Gut Microbiome and Immunotherapy Resistance. Chapter 6. Gut Microbiome and Chemotherapy Resistance. Chapter 7. Gut Microbiome Biomarkers for Cancer Diagnosis and Prognosis. Chapter 8. Microbial Metabolites and Cancer. Chapter 9. Gut-Brain Axis and Cancer Delving into the intricate connection between the gut and the brain. Chapter 10. Gut Microbiome and Cancer-Related Inflammation. Chapter 11. Diet, Lifestyle, and the Gut Microbiome. Chapter 12. Gut Microbiome and Pediatric Cancer. Chapter 13. Gut Microbiome and Systemic Side Effects of Cancer Therapies. Chapter 14. Gut Microbiome and Precision Medicine in Cancer. Chapter 15. Therapeutic Potential of the Gut Virome in Cancer. Chapter 16. Microbiome-Based Cancer Therapeutics. Chapter 17. Gut Microbiome Engineering for Cancer Therapies. Chapter 18. Future Perspectives and Challenges in Gut Microbiome Research.
About the author
Zodwa Dlamini is a Professor of Molecular Oncology and known for her unwavering commitment to advancing precision oncology. At the core of her career is her pivotal role as the Founding Director of the Pan African Cancer Research Institute (PACRI). Additionally, as the Director of the SAMRC Precision Oncology Research Unit (PORU) and a DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), she is fully committed to advancing precision medicine in the battle against cancer. Beyond her institutional leadership, Professor Dlamini also serves as a distinguished member of the American Association for Cancer Research (AACR) Regional Advisory Committee on Sub-Saharan Africa. She additionally guides the AACR Pathology Resources in Africa Advisory Group, actively identifying strategies to address gaps in cancer pathology services across the African continent. Professor Dlamini extends her contributions to the African Organisation for Research and Training in Cancer (AORTIC), where she actively influences the organization's strategic direction and mission as a member of the Research Committee Scientific Advisory Board. Her dedication to advancing cancer research in Africa was honoured with a Special Award from the Council and Executive of the African Society of Morphology and she was then admitted as an "Honorary Fellow" of the West African College of Morphologists. Moreover, she is an Overseas Fellow of the Royal Society of Medicine (London), Professional Member of the New York Academy of Sciences (USA) and a member of the Academy of Science of South Africa, highlighting her contributions to the field of Science. Through her multifaceted efforts, Professor Zodwa Dlamini remains steadfast in her commitment to shaping the ever-evolving landscape of cancer research and her journey is driven by an unshakable belief that cancer can be conquered, paving the way for a healthier and more equitable world.
Summary
This book explores the role of the gut microbiome in cancer initiation, progression, and treatment response to present gut microbiome biomarkers for cancer diagnosis and strategies for modulating microbiome for personalized cancer therapies. The work is intended for cancer researchers, medical oncologists, clinicians, and pharmacologists.
